Fitness Assessment in Young Adults Recovered From Lymphoma

NCT ID: NCT05188755

Last Updated: 2022-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2022-12-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Regular physical activity (PA) is associated with maintaining body composition, increased cardiorespiratory capacity, muscle mass and bone mineral density. In the event of a cancer, the development of physical capacities and metabolism may therefore be disturbed by cancer, these associated treatments (chemotherapy, radiotherapy and hematopoietic stem cell transplantation) but also undernutrition and the reduction in physical activity or even a sedentary lifestyle.

Although the benefits of PA in oncology are now well identified for adult populations, studies are still rare in the population of children, adolescents and young adults, and the results are still difficult to generalize. As a result, there is no recommendation on the practice of physical activity in pediatric oncology or adolescents and young adults and the levels of physical activity of cured patients remain lower than those of the general population.

Fitness is a marker of health in adults as well as in adolescents. Physical condition is a set of components such as cardiorespiratory capacity (transport and use of O2), body composition (distribution of bone, muscle and fat masses) and muscle function (strength, power, fatigue, energy metabolism) .

The investigators hypothesize that, compared to young adults, recovered from lymphoma are expected to exhibit impaired physical condition, due to physical deconditioning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Young Adults Lymphoma, Non-Hodgkin Hodgkin Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

physical fitness fat oxidation metabolism exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

group 1: healthy controls group 2 : young adults recovered from lymphoma or Hodgkin's disease
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy controls

sex and age matched healthy controls

Group Type ACTIVE_COMPARATOR

Indirect calorimetric test during submaximal exercise

Intervention Type OTHER

* metabolic evaluation by indirect calorimetry at rest and during exercise
* evaluation of cardiac output
* peripheral quantitative computed tomography (pQCT) of the muscle cross section
* evaluation of body composition
* assessment of physical capacity (chair test and 3 min step-test)
* blood test
* assess the level of physical activity

young adults recovered from lymphoma or Hodgkin's disease

young adults recovered from lymphoma or Hodgkin's disease

Group Type EXPERIMENTAL

Indirect calorimetric test during submaximal exercise

Intervention Type OTHER

* metabolic evaluation by indirect calorimetry at rest and during exercise
* evaluation of cardiac output
* peripheral quantitative computed tomography (pQCT) of the muscle cross section
* evaluation of body composition
* assessment of physical capacity (chair test and 3 min step-test)
* blood test
* assess the level of physical activity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indirect calorimetric test during submaximal exercise

* metabolic evaluation by indirect calorimetry at rest and during exercise
* evaluation of cardiac output
* peripheral quantitative computed tomography (pQCT) of the muscle cross section
* evaluation of body composition
* assessment of physical capacity (chair test and 3 min step-test)
* blood test
* assess the level of physical activity

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

cardiac output body composition assessment of physical capacity blood test accelerometry peripheral quantitative computed tomography

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Young adult male or female, aged 18 to 25
* giving free and informed consent
* Hodgkin lymphoma or non-Hodgkin lymphoma in the healing stage
* Cured (defined by an undetectable disease at the end of treatment) for at least one year and maximum 6 years of lymphoma or Hodgkin's disease

Exclusion Criteria

* Legal incapable adults
* People under judicial protection
* Treatment with systemic glucocorticoids for more than a week, during the 30 days preceding the tests
* Medical contraindication to the practice of physical exercise
* Any pathologies (other than the history of lymphoma for the cases) likely to affect the metabolism or the muscle mass
* Any treatment that may have an influence on the energy metabolism
* Active infection
* Pregnant, breastfeeding, or likely to be
* Subject's refusal to participate
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Justina Kanold

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02184-37

Identifier Type: OTHER

Identifier Source: secondary_id

RBHP 2021 KANOLD

Identifier Type: -

Identifier Source: org_study_id